Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01YGD
|
||||
Former ID |
DIB008118
|
||||
Drug Name |
ICO-25
|
||||
Synonyms |
Imuteran; Anti-MUC1 monoclonal antibodies, P Hertzen Moscow Cancer Research Institute; Anti-AG-4 antibodies, P Hertzen Moscow Cancer Research Institute
|
||||
Drug Type |
Antibody
|
||||
Indication | Breast cancer [ICD9: 174, 175; ICD10:C50] | Phase 2 | [528859] | ||
Company |
Russian National Cancer Research Center
|
||||
Target and Pathway | |||||
Target(s) | Mucin 1 | Target Info | [526513] | ||
WikiPathways | Hematopoietic Stem Cell Differentiation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.